RUCAPARIB CAMSYLATE for Illness: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 13 adverse event reports in the FDA FAERS database where RUCAPARIB CAMSYLATE was used for Illness.
Most Reported Side Effects for RUCAPARIB CAMSYLATE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Fatigue | 2,494 | 30.3% | 40 | 335 |
| Nausea | 2,219 | 26.9% | 40 | 333 |
| Malignant neoplasm progression | 1,162 | 14.1% | 69 | 139 |
| Decreased appetite | 787 | 9.6% | 17 | 148 |
| Constipation | 763 | 9.3% | 12 | 123 |
| Diarrhoea | 759 | 9.2% | 19 | 109 |
| Vomiting | 759 | 9.2% | 24 | 184 |
| Asthenia | 660 | 8.0% | 24 | 148 |
| Adverse event | 571 | 6.9% | 22 | 269 |
| Carbohydrate antigen 125 increased | 562 | 6.8% | 10 | 85 |
| Dysgeusia | 558 | 6.8% | 8 | 86 |
| Product dose omission issue | 542 | 6.6% | 2 | 42 |
| Platelet count decreased | 527 | 6.4% | 6 | 100 |
| Anaemia | 496 | 6.0% | 14 | 114 |
| Drug ineffective | 490 | 6.0% | 13 | 41 |
Other Indications for RUCAPARIB CAMSYLATE
Ovarian cancer (6,318)
Product used for unknown indication (462)
Prostate cancer (391)
Fallopian tube cancer (385)
Malignant peritoneal neoplasm (332)
Ovarian cancer recurrent (101)
Neoplasm malignant (56)
Pancreatic carcinoma (55)
Gene mutation (52)
Endometrial cancer (49)
Other Drugs Used for Illness
DUPILUMAB (4,122)
MEPOLIZUMAB (372)
CERTOLIZUMAB PEGOL (283)
ABALOPARATIDE (179)
LENALIDOMIDE (164)
TERIFLUNOMIDE (153)
SARILUMAB (130)
CABOTEGRAVIR (117)
AZTREONAM LYSINE (92)
RISANKIZUMAB-RZAA (79)